HEMODIALYSIS AND ANTIBIOTIC PROPHYLAXIS
Phase 1
- Conditions
- Blood poisoning in patients with renal failure treated with hemodialysisTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
- Registration Number
- CTIS2024-515001-26-00
- Lead Sponsor
- Region Sjaelland
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 800
Inclusion Criteria
End Stage Kidney Disease (ESKD) patients who receive an uncuffed or cuffed CVC for expected chronic HD, regardless of previous ESKD treatment modality (PD or KTX) and hemodialysis access (AV-fistula or AV-graft))
Exclusion Criteria
Unable to give informed consent, Known intolerance to beta-lactam antibiotics and clindamycin, Active infection treated with antibiotics, Pregnancy. In women of childbearing age, an approved birth control must be ensured, Patients may be rescreened later i.e. within a time period of one month from start of HD, if exclusion criteria are reversible
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: In a randomised placebo-controlled trial to evaluate the effect of prophylactic antibiotic treatment with amoxicillin/clavulanic acid (or clindamycin if beta-lactam intolerant), administered in relation to the HD procedure on: BSI and severe blood culture negative infection, during the first 6 months after initiation of hemodialysis with CVC as vascular access.;Secondary Objective: To compare the bacterial genome from pathogens isolated from blood samples with the genome of pathogens in the patient’s own microbiota, in HD patients with BSI and CVC as vascular access.;Primary end point(s): Hospitalization for BSI = 6 months after randomization, Hospitalization = 3 days due to infection defined as: CRP = 75 and negative blood cultures, treated with iv antibiotics, and occurring = 6 months after randomization
- Secondary Outcome Measures
Name Time Method